RxSight, Inc. RXST Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $17.57M-11.9% | $19.95M-32.7% | $29.63M-26.6% | $40.36M+44.1% | $28M+67.6% | ||
| $200.31M-3.8% | $208.18M+5.2% | $197.88M+5.7% | $187.14M-7.1% | $201.34M-8.7% | ||
| $750K0.0% | $750K+0.3% | $748K-0.3% | $750K0.0% | $750K0.0% | ||
| $22.44M-4.0% | $23.38M-3.2% | $24.15M-13.9% | $28.06M-9.4% | $30.96M+3.0% | ||
| $34.87M+10.5% | $31.56M+9.0% | $28.95M+15.5% | $25.06M+6.3% | $23.57M+7.1% | ||
| $4.03M-8.1% | $4.39M+34.6% | $3.26M-0.1% | $3.26M-28.1% | $4.54M0.0% | ||
| $279.23M-2.9% | $287.46M+1.3% | $283.88M0.0% | $283.87M-1.6% | $288.41M-1.8% | ||
| $13.23M+1.3% | $13.06M-0.3% | $13.1M-1.2% | $13.26M+5.6% | $12.56M+1.2% | ||
| $9.76M-2.0% | $9.96M-3.1% | $10.28M-2.9% | $10.59M-3.1% | $10.92M-2.6% | ||
| $1.03M+73.9% | $590K+10.1% | $536K-1.1% | $542K+35.2% | $401K+11.4% | ||
| $303.99M-2.5% | $311.81M+1.1% | $308.53M-0.2% | $309.01M-1.3% | $313.04M-1.7% | ||
| $7.12M+34.5% | $5.3M+56.8% | $3.38M+0.9% | $3.35M-52.9% | $7.11M+56.5% | ||
| $18.75M-5.3% | $19.8M+12.3% | $17.62M+10.6% | $15.93M+9.3% | $14.58M-28.4% | ||
| $1.47M+30.0% | $1.13M-10.4% | $1.27M+17.7% | $1.08M+5.1% | $1.02M+8.1% | ||
| $30K+7.1% | $28K0.0% | $28K+7.7% | $26K-18.8% | $32K+14.3% | ||
| $27.38M+4.3% | $26.25M+17.8% | $22.29M+9.4% | $20.38M-10.4% | $22.74M-12.1% | ||
| —— | —— | —— | —— | —— | ||
| $87K-6.5% | $93K-7.0% | $100K-5.7% | $106K-24.3% | $140K+3.7% | ||
| $10.74M-1.9% | $10.95M-4.5% | $11.47M-1.2% | $11.61M-2.5% | $11.9M-2.1% | ||
| $57K-12.3% | $65K-9.7% | $72K-10.0% | $80K-25.9% | $108K+1.9% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $36.7M+1.6% | $36.13M+11.0% | $32.56M+5.1% | $31M-8.1% | $33.73M-9.6% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $41K0.0% | $41K0.0% | $41K0.0% | $41K0.0% | $41K+2.5% | ||
| $944.24M+0.8% | $936.63M+1.0% | $927.76M+0.8% | $920.16M+1.2% | $909.55M+0.7% | ||
| -$676.92M-2.4% | -$661.04M-1.4% | -$651.89M-1.5% | -$642.07M-1.9% | -$630.29M-1.3% | ||
| -$67K-226% | $53K-11.7% | $60K+151% | -$117K-880% | $15K-91.0% | ||
| $267.3M-3.0% | $275.68M-0.1% | $275.97M-0.7% | $278.01M-0.5% | $279.32M-0.7% | ||
| $303.99M-2.5% | $311.81M+1.1% | $308.53M-0.2% | $309.01M-1.3% | $313.04M-1.7% | ||
| $1.03M+73.9% | $590K+10.1% | $536K-1.1% | $542K+35.2% | $401K+11.4% | ||
| $9.76M-2.0% | $9.96M-3.1% | $10.28M-2.9% | $10.59M-3.1% | $10.92M-2.6% | ||
| $9.76M-2.0% | $9.96M-3.1% | $10.28M-2.9% | $10.59M-3.1% | $10.92M-2.6% | ||
| $1.03M+73.9% | $590K+10.1% | $536K-1.1% | $542K+35.2% | $401K+11.4% | ||
| $200.31M-3.8% | $208.18M+5.2% | $197.88M+5.7% | $187.14M-7.1% | $201.34M-8.7% | ||
| $9.76M-2.0% | $9.96M-3.1% | $10.28M-2.9% | $10.59M-3.1% | $10.92M-2.6% | ||
| $1.03M+73.9% | $590K+10.1% | $536K-1.1% | $542K+35.2% | $401K+11.4% | ||
| $1.5M+29.4% | $1.16M-10.1% | $1.29M+17.4% | $1.1M+4.4% | $1.06M+8.3% | ||
| $18.75M-5.3% | $19.8M+12.3% | $17.62M+10.6% | $15.93M+9.3% | $14.58M-28.4% | ||
| $10.83M-1.9% | $11.04M-4.5% | $11.57M-1.3% | $11.72M-2.7% | $12.04M-2.1% | ||
| $41K0.0% | $41K0.0% | $41K0.0% | $41K0.0% | $41K+2.5% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $30K+7.1% | $28K0.0% | $28K+7.7% | $26K-18.8% | $32K+14.3% | ||
| $9.32M-5.6% | $9.88M-3.8% | $10.27M-3.2% | $10.61M-3.4% | $10.99M-3.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are RxSight, Inc.'s total assets?
- RxSight, Inc. (RXST) holds $304.0M in total assets, down 2.9% year over year.
- How much debt does RxSight, Inc. have?
- RxSight, Inc. carries $10.8M in total debt against $267.3M of shareholders' equity, a debt-to-equity ratio of 0.04.
- How much cash does RxSight, Inc. have?
- RxSight, Inc. holds $17.6M in cash and equivalents.
- Can RxSight, Inc. cover its short-term obligations?
- Its current ratio is 10.20 — current assets exceed current liabilities.
- Where does RxSight, Inc.'s balance sheet data come from?
- Every line is extracted from RxSight, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
